SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Preventive Visit — John Locke — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJohn Locke
Date of birth1632-09-08
IdentifiersMRN HR-EN001-SYN-TD; SSN (made up) 000-01-8305
Document date1692-09-17
AuthorPrudence Hartwell-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Preventive health visit at 60. [S]

History of Present Illness

Mr. Locke returns for his preventive visit, having turned 60 last week. He completed the health risk questionnaire beforehand. His asthma has been steady in the three months since tiotropium was added: he uses one or two extra inhalations of budesonide-formoterol a week, sleeps through the night, and has had no flare. The dose counters show no missed maintenance doses. He finished pulmonary rehabilitation in the spring and keeps up the walking program five days a week. The open fires in his rooms have stayed out of use, and the HEPA air cleaner runs in his study and bedroom. He spent four days in the city last month, checked the air quality index each morning, and needed his reliever twice. He has had no fever, weight loss, night sweats, or blood in his sputum. He had a normal colonoscopy eight years ago. [S]

ElementDetail
VisitPreventive health visit, age 60
Active conditionsAsthma with persistent airflow limitation on budesonide-formoterol maintenance and reliever with add-on tiotropium; exposure to air pollution
MedicinesBudesonide-formoterol 160/4.5 mcg two inhalations twice daily plus as needed; tiotropium 2.5 mcg two inhalations daily
Screening historyNormal colonoscopy eight years ago; HIV, hepatitis B, and hepatitis C tests negative in his fifties

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, better than for many years
PsychosocialLives with long-standing friends; busy with writing and his board work; no financial worries
BehavioralNever smoker; wine a few evenings a week (AUDIT-C 2); walks 30 to 40 minutes five days a week; plain diet with fruit and vegetables most days
EnvironmentalNo open fires in his rooms; HEPA air cleaner in study and bedroom; checks the air quality index before city trips
Activities of daily livingIndependent
Home safetySmoke and carbon monoxide alarms fitted; no firearms
Sexual healthNot sexually active; no risk factors for sexually transmitted infection
Hearing and visionNo hearing difficulty; reading glasses; eye examination last year
SleepSleeps through the night; no snoring reported
PainNone

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight 63.0 kg, up 1 kg since spring; no fever or night sweats
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeNo hoarseness, sore mouth, or thrush on inhaled corticosteroid; no nasal blockage
CardiovascularNegativeNo chest pain, palpitations, ankle swelling, or breathlessness lying flat
RespiratoryPositiveMild breathlessness on hills; occasional cough after city days; no wheeze at rest; no hemoptysis
GastrointestinalNegativeNo heartburn, bleeding, or change in bowel habit
GenitourinaryNegativeNo urinary hesitancy or retention on tiotropium; no nocturia
MusculoskeletalNegativeNo joint pain
IntegumentaryNegativeNo rash or easy bruising
NeurologicalNegativeNo headache, numbness, or weakness
PsychiatricNegativeMood good; PHQ-2 0

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 mcg/actuation inhaler, two puffs every 4 hours as needed while tests are done; hold for 6 hours before spirometryTwo puffs every 4 hours as neededRespiratory tract route1692-03-12 to 1692-03-26completedS
Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 4): two inhalations twice daily and one inhalation as needed for symptoms, no more than 12 inhalations a dayTwo inhalations twice daily plus one as needed; no more than 12 a dayRespiratory tract route1692-03-26activeS
Tiotropium 2.5 mcg/actuation soft-mist inhaler, two inhalations once daily (add-on long-acting muscarinic antagonist, GINA step 5)Two inhalations once a dayRespiratory tract route1692-06-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1692-09-17Body height178cmS
1692-09-17Body weight63kgS
1692-09-17Body mass index (BMI) [Ratio]19.9kg/m2S
1692-09-17Systolic blood pressure120mm[Hg]S
1692-09-17Diastolic blood pressure74mm[Hg]S
1692-09-17Heart rate74/minS
1692-09-17Respiratory rate16/minS
1692-09-17Body temperature36.6CelS
1692-09-17Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1692-09-17Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1692-09-17Cholesterol [Mass/volume] in Serum or Plasma182mg/dL<=199 mg/dLNormalS
1692-09-17Cholesterol in HDL [Mass/volume] in Serum or Plasma64mg/dL>=40 mg/dLNormalS
1692-09-17Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation101mg/dL<=129 mg/dLNormalS
1692-09-17Triglyceride [Mass/volume] in Serum or Plasma85mg/dL<=149 mg/dLNormalS

Physical Exam

Vital signs recorded on 1692-09-17; see the Vital Signs section. [S]

SystemFinding
ConstitutionalThin, well; BMI 19.9
MouthNo oral candidiasis
CardiovascularRegular rhythm; no murmur; no edema; blood pressure 120/74 mmHg
RespiratoryGood air entry; faint end-expiratory wheeze on forced expiration only; oxygen saturation 97 percent
AbdomenSoft, non-tender; no masses
SkinNo bruising or thinning

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic cough with wheeze and breathlessness since his late thirties, worse every winter and within a day of any stay in the city or by an open fire, better in warm weather and country air; night cough two or three times a week this winter; under evaluationresolvedconfirmed R05.3S — Synthetic presenting problem echoing his documented lifelong cough and breathlessness in London's coal smoke; superseded by the diagnosis at the second visit.
Long exposure to urban air pollution (decades in a large city with heavy traffic and coal and wood burning) and to indoor solid-fuel smoke from open coal and wood fires at homeactiveconfirmed Z77.110S — Synthetic modern exposure echoing the coal smoke that he, Sydenham, and Lady Masham blamed for his cough; no historical level of exposure is asserted.
Asthma with persistent airflow limitation, type 2 (eosinophilic) phenotype, in a never-smoker: post-bronchodilator FEV1/FVC 0.62, FEV1 62 percent predicted rising 380 mL after albuterol, FeNO 41 ppb, eosinophils 0.46 x 10^3/uL, IgE 186 IU/mL, normal DLCO, no emphysema on CT; aggravated by air pollution and indoor smoke; not COPDactiveconfirmed J45.40S — Synthetic modern diagnosis. His lifelong cough and breathlessness worse in coal smoke are documented (D); calling them asthma is a modern retrospective reading (R).

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, this seasonCompleted todayGiven today
COVID-19 vaccine, this seasonCompleted todayGiven today
RSV vaccineCompleted todaySingle dose given today; recommended at 60 to 74 with chronic lung disease
Recombinant zoster vaccineDueRecommended from 50; he preferred not to have a fourth injection today and will have dose 1 at his next visit
Pneumococcal conjugate vaccineUp to datePCV20 given six months ago
Tetanus boosterUp to dateTdap five years ago
Colorectal cancer screeningUp to dateNormal colonoscopy eight years ago; next due in two years
Depression screeningCompleted todayPHQ-2 0
Lipid screening and cardiovascular riskCompleted todayTotal cholesterol 182 mg/dL, HDL 64 mg/dL, LDL 101 mg/dL, triglycerides 85 mg/dL; blood pressure 120/74 mmHg; never smoker; no diabetes; estimated 10-year risk below 7.5 percent, so no statin
Diabetes screeningNot indicatedBMI 19.9 with no other risk factors
HIV, hepatitis B, and hepatitis C screeningUp to dateOne-time tests negative in his fifties
Alcohol misuse screeningCompleted todayAUDIT-C 2
Prostate cancer screeningDeclinedShared decision about PSA screening at 55 to 69 discussed; he chose not to be screened this year
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNever smoker; CT this spring showed no nodules
Hearing and visionUp to dateNo concerns; eye examination last year

Immunizations given today: Influenza vaccine, 1692-1693 season; COVID-19 mRNA vaccine, this season's formula; Respiratory syncytial virus vaccine, single dose [S]

Guideline basis: Global Strategy for Asthma Management and Prevention, 2025 update (2025); Adult Immunization Schedule by Age (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); Colorectal Cancer: Screening (2021); Depression and Suicide Risk in Adults: Screening (2023); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022); Prostate Cancer: Screening (2018); Lung Cancer: Screening (2021)

Follow-up: Asthma review next month as booked; zoster vaccine dose 1 then. Next scheduled visit 1692-10-22: asthma review two weeks after a cold with a yellow-zone flare. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 17 minutes, with his consent. He has not written a directive before. He names a long-standing friend in the household where he lives as his health care agent and took the state form to complete. He would want full treatment for any illness he might recover from, including a period on a ventilator for a severe asthma attack, and would not want his life prolonged by machines if he could not recover awareness. He asked that his health information be shared with his care team and his agent. [S]